Literature DB >> 600314

Effect of entekohepatic circulation on the pharmacokinetics of spironolactone in man.

U Abshagen, U von Grodzicki, U Hirschberger, H Rennekamp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 600314     DOI： 10.1007/bf00500971

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  9 in total

1.  The enzymatic formation of sulfoxides: the oxidation of chlorpromazine and 4,4'-diaminodiphenyl sulfide by guinea pig liver microsomes.

Authors:  J R GILLETTE; J J KAMM
Journal:  J Pharmacol Exp Ther       Date:  1960-11       Impact factor: 4.030

2.  Conversion of spironolactone to canrenone and disposition kinetics of spironolactone and canrenoate-potassium in rats.

Authors:  W Sadée; U Abshagen; C Finn; N Rietbrock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

3.  Pharmacokinetics of spironolactone, canrenone and canrenoate-K in humans.

Authors:  W Sadée; M Dagcioglu; R Schröder
Journal:  J Pharmacol Exp Ther       Date:  1973-06       Impact factor: 4.030

4.  Preparation of metabolites of spironolactone by microbial oxygenation.

Authors:  W J Marsheck; A Karim
Journal:  Appl Microbiol       Date:  1973-04

5.  Plasma levels of spirolactones in the dog.

Authors:  W Sadée; S Riegelman; S C Jones
Journal:  J Pharm Sci       Date:  1972-07       Impact factor: 3.534

6.  Pharmacokinetics of spironolactone in man.

Authors:  U Abshagen; H Rennekamp; G Luszpinski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-12       Impact factor: 3.000

7.  Isolation and identification of novel sulfur-containing metabolites of spironolactone (Aldactone).

Authors:  A Karim; E A Brown
Journal:  Steroids       Date:  1972-07       Impact factor: 2.668

8.  Formation of chlorpromazine sulphoxide and monodesmethylchlorpromazine by microsomes of small intestine.

Authors:  R Knoll; W Christ; B Müller-Oerlinghausen; H Coper
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-03       Impact factor: 3.000

9.  Disposition kinetics of spironolactone in hepatic failure after single doses and prolonged treatment.

Authors:  U Abshagen; H Rennekamp; G Luszpinski
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953
  9 in total
  8 in total

Review 1.  Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.

Authors:  Michael S Roberts; Beatrice M Magnusson; Frank J Burczynski; Michael Weiss
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of diuretics.

Authors:  B Beermann; M Groschinsky-Grind
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

3.  Digoxin-interactions in man: spironolactone reduces renal but not biliary digoxin clearance.

Authors:  A Hedman; B Angelin; A Arvidsson; R Dahlqvist
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

4.  Preliminary observations on the biliary elimination of mebendazole and its metabolites in patients with echinococcosis.

Authors:  F Witassek; R J Allan; T R Watson; W Woodtli; R Ammann; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 5.  Biliary excretion of drugs in man.

Authors:  D E Rollins; C D Klaassen
Journal:  Clin Pharmacokinet       Date:  1979 Sep-Oct       Impact factor: 6.447

6.  The effect of renal and hepatic impairment and of spironolactone on digoxin immunoassays.

Authors:  R G Morris; D B Frewin; W B Taylor; M L Glistak; D R Lehmann
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

7.  Pharmacokinetics of CamSA, a potential prophylactic compound against Clostridioides difficile infections.

Authors:  Christopher Yip; Naomi C Okada; Amber Howerton; Amei Amei; Ernesto Abel-Santos
Journal:  Biochem Pharmacol       Date:  2020-11-03       Impact factor: 5.858

8.  Preclinical study of simultaneous pharmacokinetic and pharmacodynamic herb-drug interactions between Yin-Chen-Hao-Tang and spironolactone.

Authors:  Tun-Pin Hsueh; Tung-Hu Tsai
Journal:  BMC Complement Med Ther       Date:  2020-08-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.